TransCelerate Partnership

Partnership objective

Accelerating and simplifying the drug development processes through collaboration.

TranCelerate is a joint initiative, launched in 2012, for accelerating and simplifying drug development processes through collaboration. TranCelerate is a joint initiative, launched in 2012, for accelerating and simplifying drug development processes through collaboration. Copyright Shutterstock /TranCelerate

What are the health needs and challenges?

To improve the health of people around the world by accelerating and simplifying the research and development of innovative new therapies.

Description of partnership activities and how they address needs and challenges

TranCelerate is a joint initiative, launched in 2012, for accelerating and simplifying drug development processes through collaboration. TransCelerate currently has 11 initiatives focused on the shared goals of increasing quality, patient safety and accelerating development timelines.

This program works to foster collaboration across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines.

Videos

Partnerships TV: Dalvir Gill, PhD TransCelerate BioPharma

Partnership information

Company(ies) AbbVie , Astellas , AstraZeneca , Boehringer Ingelheim , Bristol-Myers Squibb , Eli Lilly and Company , GlaxoSmithKline , Johnson & Johnson , Merck , MSD , Pfizer , Roche , Sanofi , UCB

Partner(s) Actavis, Allergan, Biogen Idec, Cubist, Medgenics, Novo Nordisk, Shionogi, TransCelerate

Type of Partner(s) NGOs, Other Business

Therapeutic Focus Other

Disease(s) General Health

Program Type(s) Availability of Treatment - Patient Safety & Medicines Quality, Availability of Treatment - Technology Transfer - Scientific Collaboration and Knowledge Sharing, Research & Development - Development of Treatments

Targeted Population(s) General population

Region(s) East Asia & Pacific, Europe & Central Asia, North America

Number of Countries 7

Country(ies) Denmark, France, Germany, Japan, Switzerland, United Kingdom, United States of America

Start Date 2012

More information TransCelerate

Anticipated completion date Ongoing